Ron Bentsur
2022 - Nuvectis Pharma
In 2022, Ron Bentsur earned a total compensation of $1.7M as President & Chief Executive Officer at Nuvectis Pharma.
Compensation breakdown
| Bonus | $431,250 |
|---|---|
| Salary | $420,360 |
| Stock Awards | $842,400 |
| Total | $1,694,010 |
Bentsur received $842.4K in stock awards, accounting for 50% of the total pay in 2022.
Bentsur also received $431.3K in bonus and $420.4K in salary.
Rankings
In 2022, Ron Bentsur's compensation ranked 2,014th out of 5,760 executives tracked by ExecPay. In other words, Bentsur earned more than 65.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,014 out of 5,760 | 65th |
Division Manufacturing | 1,078 out of 3,136 | 66th |
Major group Chemicals And Allied Products | 462 out of 1,422 | 68th |
Industry group Drugs | 424 out of 1,323 | 68th |
Industry Pharmaceutical Preparations | 308 out of 969 | 68th |
Source: SEC filing on April 29, 2024.
Bentsur's colleagues
We found two more compensation records of executives who worked with Ron Bentsur at Nuvectis Pharma in 2022.